Edesa Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edesa Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2024.
  • Edesa Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $18.4K, a 79.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.4K -$73K -79.9% Sep 30, 2024 10-K 2024-12-13
Q2 2024 $36.3K -$76.1K -67.7% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $55K -$73.4K -57.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $74.9K -$71.6K -48.9% Dec 31, 2023 10-Q 2024-02-09
Q3 2023 $91.4K +$72.9K +395% Sep 30, 2023 10-K 2024-12-13
Q2 2023 $112K +$73.4K +188% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $128K +$68.5K +114% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $147K +$68.6K +88% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 $18.5K -$78.1K -80.9% Sep 30, 2022 10-K 2023-12-15
Q2 2022 $39K -$78.8K -66.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $59.9K -$74.4K -55.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $78K -$72.4K -48.2% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $96.6K -$63.4K -39.6% Sep 30, 2021 10-K 2022-12-16
Q2 2021 $118K -$54.9K -31.8% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $134K -$47.2K -26% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $150K -$63.4K -29.7% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $160K +$160K Sep 30, 2020 10-K 2021-12-28
Q2 2020 $173K Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $181K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $214K Dec 31, 2019 10-Q 2020-02-13
Q3 2019 $0 Sep 30, 2019 10-K 2020-12-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.